Literature DB >> 11319190

Preload induces troponin I degradation independently of myocardial ischemia.

J Feng1, B J Schaus, J A Fallavollita, T C Lee, J M Canty.   

Abstract

BACKGROUND: Although global ischemia induces troponin I (TnI) degradation, regional ischemia does not. We hypothesized that this disparity is related to preload-induced proteolysis, which varies as a function of the amount of myocardium at risk of ischemia. METHODS AND
RESULTS: Isolated rat hearts were buffer-perfused at controlled levels of preload. Increasing preload to 25 mm Hg in the absence of ischemia produced pronounced TnI degradation (27 kDa versus 31 kDa bands: 16.4 +/- 3.6% versus 4.7 +/- 1.9% in immediately excised controls, P<0.05). TnI degradation could be blocked by preventing the activation of endogenous calpains with 25 micromol/L calpeptin (4.3 +/- 0.6%). This improved function, with left ventricular systolic pressure increasing from 103 +/- 4 mm Hg to 137 +/- 7 mm Hg (P<0.05). Eliminating elevations in preload after global ischemia-induced stunning also prevented TnI degradation.
CONCLUSIONS: Calpain-mediated TnI proteolysis can be dissociated from stunning and arises from elevations in preload rather than ischemia. This raises the possibility that ongoing preload-induced TnI degradation could impair myocardial function long-term.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319190     DOI: 10.1161/01.cir.103.16.2035

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  76 in total

1.  Effect of myocardial stunning on thiol status, myofibrillar ATPase and troponin I proteolysis.

Authors:  Peter Kaplan; Milena Matejovicová; Ján Lehotsky; Willem Flameng
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

2.  The protective effects and potential mechanism of Calpain inhibitor Calpeptin against focal cerebral ischemia-reperfusion injury in rats.

Authors:  Sheng Peng; Zhongshen Kuang; Yan Zhang; Hang Xu; Qinghong Cheng
Journal:  Mol Biol Rep       Date:  2010-05-16       Impact factor: 2.316

Review 3.  Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?

Authors:  Thijs M H Eijsvogels; Antonio B Fernandez; Paul D Thompson
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.

Authors:  Qi Li; Xi Lin; Xiangsheng Yang; Jiang Chang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

5.  Calpain-1-sensitive myofibrillar proteins of the human myocardium.

Authors:  Judit Barta; Attila Tóth; István Edes; Miklós Vaszily; Julius Gy Papp; András Varró; Zoltán Papp
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

Review 6.  Treatment strategies for the prevention of heart failure.

Authors:  Justin L Grodin; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2013-12

7.  Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure.

Authors:  Justin L Grodin; Sarah Neale; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  Am J Med       Date:  2014-10-15       Impact factor: 4.965

8.  Troponin Release and Reversible Left Ventricular Dysfunction After Transient Pressure Overload.

Authors:  Brian R Weil; Gen Suzuki; Rebeccah F Young; Vijay Iyer; John M Canty
Journal:  J Am Coll Cardiol       Date:  2018-06-26       Impact factor: 24.094

Review 9.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

10.  Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains.

Authors:  Min-Young Kang; Yan Zhang; Scot J Matkovich; Abhinav Diwan; Athar H Chishti; Gerald W Dorn
Journal:  Circ Res       Date:  2010-08-05       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.